APA

Han H. S., Diéras V., Robson M., Palácová M., Marcom P. K., Jager A., Bondarenko I., Citrin D., Campone M., Telli M. L., Domchek S. M., Friedlander M., Kaufman B., Garber J. E., Shparyk Y., Chmielowska E., Jakobsen E. H., Kaklamani V., Gradishar W., Ratajczak C. K., Nickner C., Qin Q., Qian J., Shepherd S. P., Isakoff S. J. & Puhalla S. (20190403). Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Han H S, Diéras V, Robson M, Palácová M, Marcom P K, Jager A, Bondarenko I, Citrin D, Campone M, Telli M L, Domchek S M, Friedlander M, Kaufman B, Garber J E, Shparyk Y, Chmielowska E, Jakobsen E H, Kaklamani V, Gradishar W, Ratajczak C K, Nickner C, Qin Q, Qian J, Shepherd S P, Isakoff S J and Puhalla S. 20190403. Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Han H. S., Diéras V., Robson M., Palácová M., Marcom P. K., Jager A., Bondarenko I., Citrin D., Campone M., Telli M. L., Domchek S. M., Friedlander M., Kaufman B., Garber J. E., Shparyk Y., Chmielowska E., Jakobsen E. H., Kaklamani V., Gradishar W., Ratajczak C. K., Nickner C., Qin Q., Qian J., Shepherd S. P., Isakoff S. J. and Puhalla S. (20190403). Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Han H S, Diéras V, Robson M, Palácová M, Marcom P K, Jager A, Bondarenko I, Citrin D, Campone M, Telli M L, Domchek S M, Friedlander M, Kaufman B, Garber J E, Shparyk Y, Chmielowska E, Jakobsen E H, Kaklamani V, Gradishar W, Ratajczak C K, Nickner C, Qin Q, Qian J, Shepherd S P, Isakoff S J and Puhalla S. Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20190403.